Pt Kalbe Farma Stock Today
| PTKFF Stock | USD 0.06 0.01 17.53% |
PerformanceVery Weak
| Odds Of DistressLow
|
PT Kalbe is trading at 0.0649 as of the 19th of March 2025. This is a 17.53 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0649. PT Kalbe has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 46.26 B outstanding shares. More on PT Kalbe Farma
Moving against PTKFF Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
PTKFF Pink Sheet Highlights
| Chairman | Bapak Vidjongtius |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
PT Kalbe Farma [PTKFF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.34 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PT Kalbe's market, we take the total number of its shares issued and multiply it by PT Kalbe's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. PT Kalbe Farma classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 46.26 B outstanding shares.
PT Kalbe Farma has accumulated about 189.29 M in cash with 2.83 T of positive cash flow from operations.
Check PT Kalbe Probability Of Bankruptcy
Ownership AllocationPT Kalbe Farma secures a total of 46.26 Billion outstanding shares. PT Kalbe shows serious amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check PTKFF Ownership Details
PT Kalbe Farma Risk Profiles
| Mean Deviation | 1.02 | |||
| Standard Deviation | 3.0 | |||
| Variance | 9.02 | |||
| Risk Adjusted Performance | (0.15) |
PTKFF Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in PT Kalbe without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
PT Kalbe Corporate Management
| Lanny Soputro | G HR | Profile | |
| Kurniawan Suhartono | Head Unit | Profile | |
| Sie Djohan | Management Devel | Profile | |
| Lukito Gozali | Head Relations | Profile |
Other Information on Investing in PTKFF Pink Sheet
PT Kalbe financial ratios help investors to determine whether PTKFF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PTKFF with respect to the benefits of owning PT Kalbe security.